Target intelligence / Profile preview

Vaginal microbiota composition and pH

Molecular classification
Microbiome, Physiological environment
01

Overview

The vaginal microbiota composition and pH constitute a dynamic biological system that serves as a critical barrier against infection. In healthy reproductive-age women, the environment is typically dominated by Lactobacillus species, which maintain a low pH (3.8–4.5) through the production of lactic acid (Ravel et al., 2011, PNAS). This acidic environment, supplemented by antimicrobial peptides and hydrogen peroxide, inhibits the overgrowth of anaerobic bacteria and the colonization of pathogens (Coudray & Madhivanan, 2020, Sex Transm Dis). Disruptions to this balance, known as dysbiosis or bacterial vaginosis, are characterized by a decrease in Lactobacilli and an increase in microbial diversity and pH. Such imbalances are clinically significant as they increase susceptibility to sexually transmitted infections, including HIV, and are linked to adverse pregnancy outcomes like preterm birth (Borgdorff et al., 2014, AIDS). Therapeutic interventions target this system by either eliminating overrepresented anaerobes with antibiotics or replenishing beneficial bacteria using live biotherapeutic products (Cohen et al., 2020, NEJM). Additionally, acidifying agents and prebiotic formulations are used to directly lower the pH and support the growth of commensal flora.

Other names
Vaginal microbiomeVaginal floraVaginal ecosystemVaginal pH
02

Mechanism of action

Restoration of Lactobacillus dominance and maintenance of an acidic environment (pH < 4.5) to inhibit the overgrowth of anaerobic bacteria and pathogens.

03

Biological functions

Pathogen defenseAcidificationImmune modulationEpithelial barrier maintenance
04

Disease associations

Bacterial vaginosisVulvovaginal candidiasisSexually transmitted infectionsPreterm birthPelvic inflammatory disease
05

Safety considerations

Vaginal irritationRisk of secondary yeast infection (Candidiasis)Antibiotic resistanceDisruption of commensal flora
06

Interacting drugs

Metronidazole

5 more in the full profile.

07

Biomarkers

Nugent scoreVaginal pHLactobacillus abundanceAmetopobium vaginae concentrationGardnerella vaginalis concentration

Beyond the preview

Go deeper on Vaginal microbiota composition and pH.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal microbiota composition and pH.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call